Home

brusc Dezvolta pur bax marker is a prognostic in colorectal Factor prost clasic în vogă

Loss of pro-apoptotic Bax and Bak increases resistance to  dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in  HCT116 colorectal cancer cells - ScienceDirect
Loss of pro-apoptotic Bax and Bak increases resistance to dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in HCT116 colorectal cancer cells - ScienceDirect

Colorectal Cancer Screening Methods and Molecular Markers for Early  Detection - Ziwei Wu, You Li, Yibin Zhang, Hui Hu, Tangwei Wu, Shuiyi Liu,  Weiqun Chen, Shenggao Xie, Zhongxin Lu, 2020
Colorectal Cancer Screening Methods and Molecular Markers for Early Detection - Ziwei Wu, You Li, Yibin Zhang, Hui Hu, Tangwei Wu, Shuiyi Liu, Weiqun Chen, Shenggao Xie, Zhongxin Lu, 2020

Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in  type II colorectal cancer cells | Oncogene
Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells | Oncogene

Bax, Bcl-2, and Bax/Bcl-2 as Prognostic Markers in Acute Myeloid Leukemia:  Are We Ready for Bcl-2-Directed Therapy? - Hematology Advisor
Bax, Bcl-2, and Bax/Bcl-2 as Prognostic Markers in Acute Myeloid Leukemia: Are We Ready for Bcl-2-Directed Therapy? - Hematology Advisor

PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and  Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to  apoptosis in cancer. - Abstract - Europe PMC
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer. - Abstract - Europe PMC

PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and  Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar

Molecular Basis of Colorectal Cancer | NEJM
Molecular Basis of Colorectal Cancer | NEJM

PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and  Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar

Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon  cancer prognosis - ScienceDirect
Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis - ScienceDirect

Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic  Options
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options

Apoptotic proteins as prognostic markers and indicators of  radiochemosensitivity in stage IIIII rectal cancers
Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage IIIII rectal cancers

Medicina | Free Full-Text | The Expression Pattern of Bcl-2 and Bax in the  Tumor and Stromal Cells in Colorectal Carcinoma | HTML
Medicina | Free Full-Text | The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma | HTML

PDF) Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and  Tumor Location in Colorectal Cancer?
PDF) Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?

Bax expression is a candidate prognostic and predictive marker of colorectal  cancer - Katkoori - Journal of Gastrointestinal Oncology
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology

Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for  the Clinical Surgeon | SpringerLink
Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon | SpringerLink

PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and  Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar

Bax expression is a candidate prognostic and predictive marker of colorectal  cancer - Katkoori - Journal of Gastrointestinal Oncology
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology

Frontiers | The role of BCL-2 family proteins in regulating apoptosis and  cancer therapy
Frontiers | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

PDF) Bax expression is a candidate prognostic and predictive marker of  colorectal cancer
PDF) Bax expression is a candidate prognostic and predictive marker of colorectal cancer

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to  apoptosis in cancer | Nature Communications
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer | Nature Communications

Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC,  MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or  without aspirin | PLOS ONE
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE

Genetic prognostic and predictive markers in colorectal cancer | Nature  Reviews Cancer
Genetic prognostic and predictive markers in colorectal cancer | Nature Reviews Cancer

The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.

Expression of the EP300, TP53 and BAX genes in colorectal cancer:  Correlations with clinicopathological parameters and survival
Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates  prolonged progression-free survival in chemotherapy-treated metastatic  melanoma | Cell Death & Disease
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma | Cell Death & Disease